-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.P1.35 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster I

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Sheng Chen1*, Dongxue Ge2*, Kun Qian3*, Jingwen Tang, MS1*, Yujun Wei4*, Liping Dou, MD5,6 and Daihong Liu, MD6*

1Medical School of Chinese PLA, Beijing, China
2Nankai University, Tianjin, China
3Nankai University, Tianjin, Tianjin, CHN
4The Fifth Medical Center of Chinese PLA General Hospital, Beijing, CHN
5The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
6Department of Hematology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China

Donatella Baronciani1*, Josu de la Fuente, PhD FRCP2, Jacques-Emanuel Galimard3*, Arnaud Dalissier, BSc4*, Ashrafsadat Mousavi5*, Akif Yesilipek6*, Hasan Hashem7*, Gulyuz Ozturk8*, Franco Locatelli, MD9, Ali Alahmari, MD10*, Javid Gaziev, MD, PhD11*, Ali Bülent Antmen, MD, PhD12*, O. Alphan Kupesiz, MD13*, Tunc Fisgin, MD14*, Giorgio La Nasa15*, Arjan C. Lankester, MD PhD16*, Eugene Goussetis, MD17*, Sandrine Bremathas, RN18* and Emanuele Angelucci, MD19

1Pesaro Hospital, Pesaro, Italy
2Imperial College Healthcare Trust, St Mary's Hospital, London, United Kingdom
3EBMT Paris Study Office, Paris, FRA
4EBMT Paris Study Unit, Saint Antoine Hospital, INSERM UMR-S 938, Sorbonne University, Paris, France
5Shariati Hospital, Teheran, Iran (Islamic Republic of)
6Medical Park Antalya Hospital, Antalya, Turkey
7King Hussein Cancer Centre, Amman, Jordan, Amman, Jordan
8Acibadem Saglik Hizmetleri ve Ticaret Anonim Sirketi, Istanbul, TUR
9IRCCS Bambino Gesù Children's Hospital, Rome, Italy
10Department of Hematology, Stem Cell Transplantation, and Cellular Therapy, Cancer Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
11Mediterranean Institute of Hematology, Rome, ITA
12Department of Pediatric Hematology, Acibadem Adana Hospital, Adana, Turkey
13Dumlupinar Bulvari, Antalya, TUR
14Altinbas University, Faculty of Medicine, Bahcelievler Medicalpark Hospital, Pediatric BMT Unit, Istanbul, Türkiye, Istambul, Turkey
15Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy
16Division of Stem cell Transplantation, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands
17Stem Cell Transplant Unit, "Agia Sofia" Children's Hospital, Athens, Greece, Athens, Greece
18IMPERIAL COLLEGE HEALTHCARE NHS TRUST, London, United Kingdom
19Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, ITA

Maxime Jullien, MD1,2*, Catherine Willem1,3*, Perla Salameh1,3*, Enora Ferron1,3*, Alice Garnier, MD4*, Pierre Peterlin5*, Amandine Le Bourgeois, MD2*, Thierry Guillaume, MD, PhD1,2*, Katia Gagne, PhD1,3*, Patrice Chevallier, MD, PhD1,6 and Christelle Retiere, PhD1,3*

1Inserm UMR 1307, CNRS UMR 6075 - Team 12, Nantes University, Nantes, France
2Hematology Clinic, Nantes University Hospital, Nantes, France
3Etablissement Francais du Sang, Nantes, France
4CHU Nantes Hôpital Hôtel Dieu Hématologie Clinique, Nantes, France
5Nantes University Hospital, Nantes, France
6Hematology Department, Nantes University Hospital, Nantes, France

Guangyu Sun1*, Jie Chen2*, Baolin Tang1*, Yongsheng Han1*, Xiang Wan1*, Yaxin Cheng1*, Qian Fan1*, Ziwei Zhou1*, Yanqiu Li3*, Ying Zhang3* and Xiaoyu Zhu1

1Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
2Nuwacell Biotechnologies Co., Ltd., Hefei, AL, China
3Nuwacell Biotechnologies Co., Ltd., Hefei, Anhui, China

Hongwen Xiao, MD1*, Gaohui Yang1*, Huang Qiulin, PhD Candidate1*, Zhenbin Wei1*, Zhaoping Gan1*, Meiqing Wu1*, Zeyan Shi1*, Huicheng Huang1*, Zhaofang Pan1*, Lianjin Liu1*, Lingling Shi, MD1*, Zhongming Zhang1*, Qifa Liu, MD2, Rongrong Liu, MD1,3,4* and Yongrong Lai, MD1,3,4*

1Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
2Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
3Guangxi Key Laboratory of Thalassemia Research, Nanning, China
4NHC Key Laboratory of Thalassemia Medicine, Nanning, China

Yan-ou Yang1*, Alina Volkova2,3*, Victor Sokolov2,3*, Xing Liu1*, Cristina Leon2*, Yuri Kosinsky, PhD4*, Jennifer Sheng, PhD1* and Xuejun Chen, PhD1*

1Incyte Corporation, Wilmington, DE
2M&S Decisions FZ-LLC, Dubai, United Arab Emirates
3Marchuk Institute of Numerical Mathematics RAS, Moscow, Russian Federation
4Modeling and Simulation Decisions FZ-LLC, Dubai, United Arab Emirates

Muhammad Umair Mushtaq1,2,3, Amir Kasaeian1,3*, Muhammad Kashif Amin, MD1,2,3*, Aqeeb Ur Rehman, MD1*, Naghmeh Khavandgar1,3*, Hediyeh Alemi1,3*, Sibgha Gull Chaudhary, MD1,2,3*, Iqra Anwar, MBBS1,3*, Matthew McGuirk1,3*, Haitham Abdelhakim, MD3,4, Anurag K. Singh, MD1,2,3, Mehdi Hamadani, MD3,5, Joseph P. McGuirk, DO1,2,3 and Moazzam Shahzad, MD3,6

1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
3Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
4Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
5Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
6Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL

Marianna Maffeis1*, Giulia Albrici2*, Giulia Baresi2*, Stefano Rossi2*, Elena Soncini2*, Vincenzo Pintabona2*, Richard Fabian Schumacher2*, Alessandra Beghin3*, Federica Bolda3*, Marta Comini3*, Arnalda Lanfranchi3* and Fulvio Porta2*

1Pediatric Oncohematology and Bone Marrow Transplant Unit, Children's Hospital, ASST Spedali Civili, Brescia, AL, Italy
2Pediatric Oncohematology and Bone Marrow Transplant Unit, Children's Hospital, ASST Spedali Civili, Brescia, Italy
3Stem Cell Laboratory, Section of Hematology and Blood Coagulation, Diagnostic Department, ASST Spedali Civili, Brescia, Italy

Leena Chehab, MS1,2*, Caitlin W. Elgarten, MD1,3*, Yimei Li, PhD3,4*, Anne Wohlschlaeger, MSN, RN, CRNP5*, Jason L. Freedman, MD, MSCE3*, Timothy S. Olson, MD, PhD5,6, Brian T. Fisher, DO, MPH, MSCE4,7* and Sogol Mostoufi-Moab, MD, MSCE1,3*

1Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
2Division of Oncology, Children's Hospital of Philadelphia, Gaithersburg, MD
3Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
4Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
5Children's Hospital of Philadelphia, Philadelphia, PA
6Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
7Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA

Xinhui Zheng*, Xin Chen*, Yawei Zheng*, Weihua Zhai*, Donglin Yang*, Jialin Wei*, Aiming Pang*, Mingzhe Han* and Erlie Jiang, PhD

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Victoria Stepanyants, BSc1, Hong Li, PhD2*, Danielle Cenin, PharmD3*, Jessi Edwards, PharmD4*, Claudio Brunstein, MD, PhD5, Matt Kalaycio, MD6, Ronald Sobecks, MD7, Craig S. Sauter, MD8 and Betty K. Hamilton, MD9

1Cleveland Clinic Lerner College of Medicine, Cleveland Heights, OH
2Department of Biostatistics and Quantitative Health Sciences, Cleveland Clinic, Cleveland
3Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland
4Cleveland Clinic, Cleveland
5Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
7Blood and Marrow Transplant, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
8Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
9Cleveland Clinic Foundation, Cleveland, OH

Alicja Sadowska-Klasa, MD1,2, Danniel Zamora, MD1*, Hu Xie1*, Terry Stevens-Ayers1*, Wendy M Leisenring1*, Bradley Edmison1*, Marco Mielcarek, MD1 and Michael Boeckh, MD1,3*

1Fred Hutchinson Cancer Center, Seattle, WA
2Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
3University of Washington, Seattle, WA

Moazzam Shahzad, MD1,2, Aqeeb Ur Rehman, MD1,3*, Muhammad Kashif Amin, MD1,3,4*, Aleenah Mohsin1,3*, Sibgha Gull Chaudhary, MD1,3,4*, Iqra Anwar, MBBS1,3*, Jawad Noor, MD1,3*, Rajat Bansal, MD1,3*, Matthew McGuirk1,3*, Anurag K. Singh, MD1,3,4, Mehdi Hamadani, MD1,5, Joseph P. McGuirk, DO1,3,4 and Muhammad Umair Mushtaq3,4,6

1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
2Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
4US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
5Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
6MRF, Kansas City

Lei Wang, MD1*, Ruigeng Yang, MS1*, Shufeng Li, PhD2*, Jiancheng Fang, MD1*, Xiaofei Luo2*, Wenli Sun, MS1*, Chunfei Jiang, MS1*, Meng Li, MD3*, Yang Xue, MD1* and Hongxing Liu, MD1,4,5,6,7,8

1Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
2Beijing Hexin Technology Co., Ltd., Beijing, China
3Department of Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China
4Department of Laboratory Medicine, Lu Daopei Hematology & Oncology Center, Hebei Yanda Hospital, Langfang, China
5Pathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Langfang, Hebei, China
6Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China
7Pathology & Laboratory Medicine Division, Beijing Lu Daopei Institute of Hematology, Pathology & Laboratory Medicine Division, Beijing, China
8Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China

Armin Rashidi, MD, PhD1, Swetha Reddi, MD2*, Maryam Ebadi, MD3, Liliia Senyshyn, MD1*, Amanda Kabage4*, Samuel Minot, PhD5*, Ted Gooley, PhD6*, Stephanie J. Lee, MD, MPH1, Geoffrey R. Hill, MD7 and Alexander Khoruts, MD4*

1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
2Department of Internal Medicine, University of Washington, Seattle, WA
3Department of Radiation Oncology, University of Washington and Fred Hutch Cancer Center, Seattle, WA
4Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN
5Microbiome Research Initiative, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA
6University of Washington, Seattle, WA
7Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA

Aswin Anand Pai, MSc, PhD1*, John C Panetta2*, Nayanthara Bijukumar1*, Rachel Mariam Renji1*, Manoj A1*, Agila Jayaraman1*, Sujith Karumathil1*, Anu Korula, MD, DM, MRCP3*, Sushil Selvarajan, MD, DM1*, Alok Srivastava, MD, FRACP, FRCPA, FRCP1, Aby Abraham, MD, DM1*, Vikram Mathews, MD, DM4, Biju George, MD, DM1, Uday Kulkarni, MD, DM1 and Poonkuzhali Balasubramanian, MSc, PhD1

1Department of Haematology, Christian Medical College Ranipet Campus, Ranipet, India
2Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
3Department of Haematology, Christian Medical College & Hospital, Vellore, India
4Department of Haematology, Christian Medical College Vellore, Ranipet Campus, India

Mohammed Kawari, MD1*, Mariana Pinto Pereira, MD1*, Mats Remberger, PhD2*, Ambrose Lau, MD1*, Arjun Law, MD3, Rajat Kumar, MD PhD1, Igor Novitzky-Basso, MD, PhD1, Wilson Lam, MD1, Ivan Pasic, MD1*, Armin Gerbitz, MD, PhD1*, Auro Viswabandya, MD1, Dennis Dong Hwan Kim, MD, PhD4, Jonas Mattsson, MD, PhD1* and Fotios Michelis, MD1*

1Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
2Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
3Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, Canada
4Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Cuifeng Huang1*, Gaohui Yang1*, Lingling Shi, MD1*, Lianjin Liu1*, Zhongming Zhang1*, Zhenbin Wei1*, Beicai Liu1*, Zhaoping Gan1*, Wenqiang Xie1*, Rui Huang1*, Na Sun1*, Meiqing Wu1*, Xuemei Zhou1*, Yinghua Chen1*, Yanye Liu1*, Zhi Li1*, Zhaofang Pan1*, Huicheng Huang1*, Qifa Liu, MD2, Rongrong Liu, MD1,3,4* and Yongrong Lai, MD1,3,4*

1Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
2Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
3NHC Key Laboratory of Thalassemia Medicine, Nanning, China
4Guangxi Key Laboratory of Thalassemia Research, Nanning, China

Adela Maria Neagoie1*, Conrad Weidt, MD2*, Daniel Fürst, MD3,4*, Verena Wais, MD2*, Christian Sinzger, MD5*, Katrin Strauss, MD2*, Katharina Göhring, MD5*, Jacqueline Schnell, MD2*, Michaela Feuring, md6*, Thomas Stamminger, MD7*, Hartmut Döhner, MD2, Donald Werner Bunjes, MD2* and Elisa Sala, MD2*

1Department of Internal Medicine III, University Hospital Ulm, Ulm, AL, Germany
2Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
3Department of Transplantation Immunology, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Ulm, Germany
4German Red Cross Blood Transfusion Services Baden-Württemberg-Hessia, Ulm, Germany
5Institute for Virology, University Hospital Ulm, Ulm, Germany
6Ulm University Hospital, Ulm, Germany
7Institute for Virology, University Hospital UIm, Ulm, Germany

Udit Nangia, MD1, Leland Metheny, MD2, Deepak Chandramohan, MD3*, Hari Naga Garapati, MD4*, Prathap Simhadri, MD5* and Neeraj Mahajan, MD6*

1University Hospitals - Parma Medical Center, Vernon Hills, IL
2Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
3The University of Alabama at Birmingham, Birmingham, AL
4Baptist Medical Center South, Montgomery, AL
5AdventHealth East Florida, Daytona Beach, FL
6University Hospitals - Parma Medical Center, Parma, OH

Panagiotis Tsirigotis*, Ioanna Lazana, MD, PhD, Ioannis Konstantellos, MD*, Maria Stamouli, MD, PhD*, Konstantinos Gkirkas, MD, PhD*, Spiros Chondropoulos*, Pinelopi Vryttia, MD*, Georgia Gkolfinopoulou* and Panagiota Katsiampoura*

ATTIKO UNIVERSITY HOSPITAL, ATHENS, GREECE, Greece

Rodrigo Gil Manso1*, Cristina Hidalgo2*, Laura Puebla Tornero3*, Almudena Cabero Martínez4*, Ana García Bacelar1*, Ana Africa Martin Lopez, MD1*, Monica Cabrero Calvo, MD1*, Monica Baile Gonzalez1*, Estefanía Pérez López, MD1*, Alejandro Avendaño Pita1*, Lourdes Vazquez Lopez1*, Jenifer Alonso Rodriguez1*, Fermin Sanchez-Guijo, MD, PhD1 and Lucia Lopez Corral, MD1*

1Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
2Reumatology Department, University Hospital of Salamanca, SAlamanca, Spain
3Dermatology Department, University Hospital of Salamanca, Salamanca, Spain
4Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), La Bañeza, Leon, Spain

Kyoko Fuse, MD, PhD1,2, Tatuya Suwabe, MD, PhD1*, Takayuki Katagiri, MD, PhD3*, Yasuhiko Shibasaki, MD, PhD2*, Hirohito Sone, MD, PhD2* and Masayoshi Masuko, MD, PhD1

1Department of Haematopoietic Cell Therapy, Niigata University Medical and Dental Hospital, Niigata, Japan
2Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan
3Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata-shi chuo-Ku, Japan

*signifies non-member of ASH